GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Dr Reddy's Laboratories Ltd DRREDDY.NS · INR

Pharmaceuticals · NSE · 🇮🇳 India

Nifty 50

Compare

1,385.00

+0.87%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹335.93bn

FY2017FY2026

Net income

₹42.85bn

FY2017FY2026

Free cash flow

₹18.33bn

FY2017FY2026

Shareholders' equity

₹377.06bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹335.93bn₹326.44bn₹280.11bn₹246.70bn₹215.45bn₹190.47bn₹175.17bn₹154.48bn₹142.81bn₹141.96bn
Gross profit₹177.26bn₹218.60bn₹190.71bn₹163.65bn₹135.48bn₹124.83bn₹115.04bn₹104.69bn₹97.61bn₹99.88bn
Research and development₹24.06bn₹27.38bn₹22.87bn₹19.38bn₹17.48bn₹16.54bn₹15.41bn₹15.61bn₹18.27bn₹19.51bn
Operating income₹50.12bn₹72.03bn₹64.63bn₹53.42bn₹26.02bn₹32.91bn₹29.31bn₹19.83bn₹11.13bn₹14.53bn
Net income₹42.85bn₹56.55bn₹55.78bn₹45.07bn₹21.82bn₹19.52bn₹20.26bn₹19.50bn₹9.47bn₹12.92bn
Diluted earnings per share51.4667.8766.8654.0726.2323.4724.3523.5311.4015.56

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹579.35bn₹492.99bn₹388.64bn₹322.85bn₹297.47bn₹266.17bn₹232.25bn₹224.66bn₹225.44bn₹218.16bn
Cash and short-term investments—₹57.76bn₹81.31bn₹61.64bn₹44.21bn₹34.39bn₹25.62bn₹24.63bn₹20.90bn₹18.07bn
Total liabilities₹198.89bn₹155.82bn₹106.09bn₹89.99bn₹105.34bn₹89.75bn₹76.27bn₹84.42bn₹99.73bn₹95.54bn
Debt₹12.20bn₹45.91bn₹18.71bn₹8.67bn₹32.83bn₹29.44bn₹17.84bn₹34.13bn₹50.65bn₹49.08bn
Shareholders' equity₹377.06bn₹333.39bn₹282.55bn₹232.86bn₹192.12bn₹176.42bn₹155.99bn₹140.24bn₹125.72bn₹122.62bn
Shares outstanding833m833m834m834m832m832m832m829m831m831m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹56.76bn₹46.43bn₹45.43bn₹58.88bn₹28.11bn₹35.70bn₹29.84bn₹28.70bn₹18.03bn₹21.51bn
Capital spending−₹38.42bn−₹34.40bn−₹27.43bn−₹18.87bn−₹14.66bn−₹9.74bn−₹4.85bn−₹6.96bn−₹9.29bn−₹12.28bn
Free cash flow₹18.33bn₹12.03bn₹18.00bn₹40.01bn₹13.45bn₹25.96bn₹25.00bn₹21.75bn₹8.74bn₹9.23bn
Dividends paid−₹6.66bn−₹6.66bn−₹6.65bn−₹4.98bn−₹4.15bn−₹4.15bn−₹3.31bn−₹3.32bn−₹3.32bn−₹3.31bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹80.70bn₹75.16bn₹87.53bn₹88.28bn₹85.72bn₹85.28bn₹83.81bn₹80.38bn
Gross profit₹37.54bn₹43.03bn₹56.58bn₹57.05bn₹57.65bn₹56.78bn₹58.00bn₹56.72bn
Operating income—₹829.0m₹14.33bn₹15.05bn₹16.98bn₹17.35bn₹18.71bn₹18.05bn
Net income₹4.43bn₹2.21bn₹12.10bn₹13.47bn₹14.18bn₹15.93bn₹14.14bn₹12.56bn
Diluted earnings per share5.332.6514.5216.1717.0219.1216.9415.05
Cash from operations−₹927.0m₹15.64bn₹10.91bn₹30.20bn₹14.63bn₹46.43bn₹6.62bn₹17.81bn
Capital spending−₹3.70bn−₹10.82bn−₹7.32bn−₹20.28bn−₹10.15bn−₹34.40bn−₹8.82bn−₹14.33bn
Free cash flow−₹4.63bn₹4.82bn₹3.59bn₹9.92bn₹4.48bn₹12.03bn−₹2.20bn₹3.48bn
Total assets₹575.30bn₹579.35bn₹562.90bn₹543.73bn₹519.54bn₹494.27bn₹481.06bn₹467.28bn
Cash and short-term investments———₹73.97bn—₹61.05bn—₹66.45bn
Debt—₹12.20bn—₹11.64bn—₹7.86bn₹3.80bn₹7.36bn
Shareholders' equity₹383.43bn₹377.06bn₹372.37bn₹360.14bn₹350.06bn₹335.50bn₹317.72bn₹307.49bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue10.8%12.0%8.0%
Operating income-2.1%8.8%5.0%
Net income-1.7%17.0%7.2%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin59.8%63.1%63.4%65.1%
Operating margin18.4%20.2%18.8%17.1%
Net margin15.0%16.8%15.1%13.7%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings26.618.720.721.532.341.842.824.445.931.0
Price to sales3.43.34.13.93.34.35.03.13.02.8

Dividends and splits

Per share, in the currency the company pays

Paid for 31 years. Last went ex-dividend on 10 Jul 2026.

FY2027FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year8.008.008.008.006.005.005.004.00
  • 5-for-1 split · 28 Oct 2024
  • 2-for-1 split · 28 Aug 2006
  • 2-for-1 split · 15 Oct 2001
  • 2-for-1 split · 10 Oct 2001

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.